Clinical Trial Update: Efficacy and Safety of MEDI7352 in Participants With Painful Diabetic Neuropathy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating MEDI7352 for Painful Diabetic Neuropathy has been terminated, with results posted on 2024-09-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Painful Diabetic Neuropathy

Drugs mentioned

• MEDI7352

Snippet

Sponsor: AstraZeneca | Conditions: Painful Diabetic Neuropathy | Phase 2 | Status: TERMINATED | Results posted: 2024-09-19